Cytolethal distending toxin enhances Escherichia coli urinary tract infection
Infection and Immunity · 11.08.2026 · 94 (8)
DOI: 10.1128/iai.00103-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection and Immunity, erschienen am 11.08.2026. Verfasst von Santosh Paudel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Michigan, Michigan Medicine, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Urinary Tract Infections, Bacterial Toxins, Escherichia coli Infections, Escherichia coli. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Cytolethal distending toxin (CDT) is a virulence factor produced by several gram-negative bacteria, including Escherichia coli , the most prevalent etiological agent of urinary tract infections (UTIs). CDT causes DNA damage to eukaryotic cells, leading to the impairment of host defenses by disrupting epithelial barriers, suppressing acquired immunity, and promoting pro-inflammatory responses. E. coli strains encoding CDT have been previously identified in samples from UTI patients; however, the specific function of CDT in the development of UTI remains undefined. In this study, we used a mouse model of ascending UTI to determine the role of CDT during infection. An E. coli mutant strain lacking the cdtABC locus was generated and combined with wild-type bacteria to co-infect mice via transurethral inoculation. At 1 day post-inoculation, competitive indices demonstrated a significant disadvantage for the cdt mutant in urine, bladder, and kidneys. Single-strain infections were also performed as a further assessment of CDT impact, demonstrating that the cdt mutant had reduced kidney colonization, indicative of CDT contributions to pyelonephritis. Histopathological analysis of the urinary bladder and kidney tissues from mice infected with CDT-encoding E. coli demonstrated higher levels of inflammation and tissue damage within the kidneys at both 1 and 7 days post-inoculation and in the bladder after 7 days when compared to mice infected with cdt mutant bacteria. Collectively, these findings identify a role for CDT in UTI pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Michigan, Michigan Medicine, Ann Arbor, Michigan, USA.
- Unit for Laboratory Animal Medicine Pathology Core, University of Michigan, Michigan Medicine, Ann Arbor, Michigan, USA.
ORCID-Profile: Santosh Paudel, Melanie M Pearson, Mark T Anderson
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Paudel, S., Curtis, B. E., Stefa, S., Mobley, H. L. T., Pearson, M. M., & Anderson, M. T. (2026). Cytolethal distending toxin enhances Escherichia coli urinary tract infection. Infection and Immunity, 94(8). https://doi.org/10.1128/iai.00103-26
Vancouver
Paudel S, Curtis BE, Stefa S, Mobley HLT, Pearson MM, Anderson MT. Cytolethal distending toxin enhances Escherichia coli urinary tract infection. Infection and Immunity. 2026;94(8). doi:10.1128/iai.00103-26
BibTeX
@article{Paudel2026,
author = {Paudel, Santosh and Curtis, Benjamin E and Stefa, Siena and Mobley, Harry L T and Pearson, Melanie M and Anderson, Mark T},
title = {Cytolethal distending toxin enhances Escherichia coli urinary tract infection},
journal = {Infection and Immunity},
year = {2026},
volume = {94},
number = {8},
doi = {10.1128/iai.00103-26}
}
EUVIMED